What is Pegunigalsidase Alfa: Uses, Dosage, Side Effects and More

Pegunigalsidase alfa is a specialized enzyme replacement therapy designed to treat Fabry disease, a rare genetic condition. This medication works by replacing the missing or deficient enzyme that people with Fabry disease lack, helping their bodies break down certain fatty substances that would otherwise build up and cause damage.

If you or a loved one has been diagnosed with Fabry disease, you might feel overwhelmed by the treatment options. This medication represents a significant advancement in care, offering hope for managing symptoms and protecting your organs from long-term damage.

What is Pegunigalsidase Alfa?

Pegunigalsidase alfa is a man-made version of an enzyme called alpha-galactosidase A. People with Fabry disease either don't produce enough of this enzyme or produce a version that doesn't work properly.

Think of this enzyme as a special key that unlocks and breaks down fatty substances in your cells. Without this key, these substances pile up like clutter in a room, eventually causing problems throughout your body. This medication provides your body with working copies of that missing key.

The medication is given through an intravenous (IV) infusion, which means it's delivered directly into your bloodstream through a vein. This ensures the enzyme reaches all parts of your body where it's needed most.

What is Pegunigalsidase Alfa Used For?

Pegunigalsidase alfa is specifically approved to treat adults with Fabry disease. Fabry disease is a rare genetic condition that affects how your body processes certain fats, leading to a buildup of harmful substances in your cells.

This buildup can cause serious problems over time, including kidney damage, heart complications, stroke, and severe pain episodes. The medication helps prevent or slow down these complications by breaking down the accumulated fatty substances.

Your doctor will typically recommend this treatment if you have confirmed Fabry disease and are experiencing symptoms or showing signs of organ involvement. The goal is to protect your kidneys, heart, and other organs while improving your quality of life.

How Does Pegunigalsidase Alfa Work?

Pegunigalsidase alfa works by replacing the faulty enzyme that causes Fabry disease. Once infused into your bloodstream, the medication travels throughout your body and enters your cells where it's needed most.

Inside your cells, the enzyme breaks down globotriaosylceramide (Gb3), the fatty substance that accumulates in Fabry disease. This process helps clear the buildup that has been causing damage to your organs and tissues.

The medication is considered a potent enzyme replacement therapy, meaning it's quite effective at doing the job your body's natural enzyme should be doing. However, because your body continues to produce the problematic substances, you'll need regular infusions to maintain the therapeutic effect.

How Should I Take Pegunigalsidase Alfa?

Pegunigalsidase alfa is given as an intravenous infusion in a healthcare setting, typically a hospital or infusion center. You cannot take this medication at home or by mouth.

Before your infusion, your healthcare team will prepare the medication and set up an IV line. The infusion usually takes about 1 to 3 hours, depending on your specific dose and how well you tolerate the treatment.

You don't need to fast before your infusion, but it's wise to eat a light meal beforehand to help prevent any potential nausea. Stay well-hydrated by drinking plenty of water in the hours leading up to your appointment.

During the infusion, you'll be monitored closely for any reactions. Many people find it helpful to bring a book, tablet, or other quiet activities to pass the time comfortably.

How Long Should I Take Pegunigalsidase Alfa For?

Pegunigalsidase alfa is typically a lifelong treatment for Fabry disease. Because this is a genetic condition, your body will continue to lack the enzyme you need, making ongoing replacement therapy necessary.

Most people receive infusions every two weeks, though your doctor will determine the exact schedule based on your individual needs and response to treatment. Missing doses can allow harmful substances to build up again in your cells.

Your healthcare team will regularly monitor your response to treatment through blood tests and other assessments. These check-ups help ensure the medication is working effectively and allow for any necessary adjustments to your care plan.

What Are the Side Effects of Pegunigalsidase Alfa?

Like all medications, pegunigalsidase alfa can cause side effects, though many people tolerate it well. Most side effects are mild to moderate and often improve as your body adjusts to the treatment.

Here are the more common side effects you might experience:

• Infusion-related reactions like headache, fatigue, or mild fever
• Nausea or stomach discomfort
• Muscle or joint pain
• Skin reactions at the infusion site
• Mild allergic reactions such as itching or rash

These common reactions are usually manageable and often decrease over time as your body becomes accustomed to the treatment.

More serious but less common side effects can include:

• Severe allergic reactions (anaphylaxis) with difficulty breathing or swelling
• Significant drops in blood pressure during infusion
• Chest pain or heart rhythm changes
• Severe headaches or neurological symptoms
• Kidney function changes

Your healthcare team knows how to recognize and manage these reactions quickly. That's why you'll always receive your infusions in a medical setting with trained professionals nearby.

Who Should Not Take Pegunigalsidase Alfa?

Pegunigalsidase alfa isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for you. People with severe allergies to the medication or its components should not receive this treatment.

Your doctor will be especially cautious if you have a history of severe allergic reactions to other enzyme replacement therapies. They'll also consider your overall health status and any other medical conditions you might have.

Pregnant or breastfeeding women should discuss the risks and benefits with their healthcare provider, as there's limited safety data for these situations. Your doctor will help weigh the potential benefits against any possible risks.

If you have active infections or are immunocompromised, your doctor might delay treatment until your condition stabilizes. They want to ensure your body can handle the medication safely.

Pegunigalsidase Alfa Brand Name

Pegunigalsidase alfa is marketed under the brand name Elfabrio. This brand name is what you'll typically see on your prescription and medical records.

Elfabrio is manufactured by Chiesi Global Rare Diseases and received approval from the FDA in 2023. Knowing the brand name can help you communicate more effectively with your healthcare team and insurance providers.

When discussing your treatment with doctors, pharmacists, or insurance representatives, you can use either the generic name (pegunigalsidase alfa) or the brand name (Elfabrio) - both refer to the same medication.

Pegunigalsidase Alfa Alternatives

There are other enzyme replacement therapies available for Fabry disease, though each has its own characteristics and administration schedule. Agalsidase alfa (Replagal) and agalsidase beta (Fabrazyme) are two other options your doctor might consider.

Some people might also be candidates for substrate reduction therapy with migalastat (Galafold), which works differently by helping your body's own faulty enzyme work better. However, this option only works for people with specific genetic mutations.

Your doctor will help determine which treatment is most appropriate for your specific type of Fabry disease and your individual health situation. Each person's genetic makeup and disease progression can influence which therapy works best.

Is Pegunigalsidase Alfa Better Than Agalsidase Beta?

Both pegunigalsidase alfa and agalsidase beta are effective treatments for Fabry disease, but they have some differences that might make one more suitable for you than the other.

Pegunigalsidase alfa is a newer medication that's designed to last longer in your body, potentially providing more sustained enzyme activity. Some studies suggest it may be less likely to trigger immune reactions that can reduce effectiveness over time.

Agalsidase beta has been available longer and has more extensive long-term safety data. However, some people develop antibodies against it, which can reduce its effectiveness and increase the risk of allergic reactions.

Your doctor will consider factors like your previous treatment history, any allergic reactions you've had, and your specific disease characteristics when recommending the best option for you.